SureTrader Nadex Advertisement PGUS
Home > Boards > US Listed > Medical - Drugs >

Kitov Pharmaceuticals Hldgs L Sponsored ADR (KTOV)

Add KTOV Price Alert      Hide Sticky   Hide Intro
Search This Board: 
Last Post: 3/27/2017 12:46:11 PM - Followers: 119 - Board type: Free - Posts Today: 0



US Office

1615 Suter’s Lane NW, Washington DC 20007, Tel:  +1-202-965-2215

Israel Office

One Azrieli Center, Round Tower, Tel Aviv 6701101


Kitov Pharmaceuticals Holdings Ltd is an Israel-based company that develops non-steroidal anti-inflammatory drugs
that treat pain without raising blood pressure, thus avoiding the increased risk of heart attacks, strokes or death.

Kitov is developing combination drug products that treat the pain of osteoarthritis without causing cardiovascular problems.
These drugs will not only not need to be labeled with health warnings, but will actually be labeled as reducing the risk of
cardiovascular events. Kitov’s drugs have the potential to improve the health of millions of patients worldwide.
It is expected that physicians will prefer to prescribe them rather than prescribe two separate drugs, to improve their patients’ health and to reduce their own legal exposure.

Kitov is currently focusing two late-stage drugs. Both contain NSAIDs that are widely consumed throughout the world for treating osteoarthritis.
Each of Kitov’s drugs adds to the NSAID a second drug product that reduces hypertension.

KIT-301: Naproxen combined with anti-hypertension. Ready for phase III clinical trial. New Drug Application (NDA) scheduled
for 20-24 months from start of development.
KIT-302: Celecoxib combined with anti-hypertension. Ready for phase III clinical trial. New Drug Application (NDA) scheduled for 2015.

Osteoarthritis, affecting approximately half of all adults over the age of 50, is a degenerative disease of joints that can cause pain and limit mobility.
Exercise and weight control are important therapies for controlling symptoms, but for many patients medication is the next step in pain treatment.
Non-steroidal anti-inflammatory drugs (NSAIDs) are the most commonly used medications for treating osteoarthritis pain.
However, these medications raise blood pressure (hypertension) and thereby increase the risk of heart attacks, strokes, and death.
This has led the US FDA to require including a black box warning in the labeling of all NSAIDs, warning of these increased cardiovascular risks.


Dr. John Paul Waymack – M.D., Sc.D.

Chairman of the Board of Directors and Chief Medical Officer

Dr. Waymack was one of the founders of Kitov Pharmaceuticals and has served as the Chairman of our Board of Directors and Chief Medical Officer since July 2013. Dr. Waymack has over 20 years of experience in the biopharma field. Dr. Waymack is a former academic transplant surgeon and a former FDA medical officer, with over fifteen years of experience in drug development as a consultant to major pharmaceutical companies, including Pfizer, Roche, Pharmacia, Warner Lambert and Searle. During his 10 years of academic career, Dr. Waymack published over 100 scientific essays, mainly in the fields of prostaglandins and immunology. In addition, Dr. Waymack volunteered to the U.S. army, where he was commissioned and served as a Major in the Medical Corp. in the position of Chief of Surgical Research in the U.S. Army’s Institute for Surgical Research. Dr. Waymack was also an associate professor of surgery at the University of Texas Medical Branch and at the University of Medicine and Dentistry of New Jersey.



Dec. 17, 2015 :  Kitov Pharmaceuticals Reports Additional Data from its Phase III Trial on the Beneficial Blood Pressure Effects of KIT-302

November 20, 2015 : Kitov Pharmaceuticals Holdings Announces Pricing of U.S. Initial Public Offering and NASDAQ Listing

October 21, 2015 : Kitov Pharma Announces Completion of Patient Recruitment for the Phase III Clinical Trial for KIT-302


  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
Current Price
Bid Ask Day's Range
KTOV News: Report of Foreign Issuer (6-k) 03/27/2017 05:20:25 PM
KTOV News: Report of Foreign Issuer (6-k) 03/17/2017 04:03:37 PM
KTOV News: Report of Foreign Issuer (6-k) 03/08/2017 09:01:22 AM
KTOV News: Report of Foreign Issuer (6-k) 03/03/2017 06:07:34 AM
KTOV News: Report of Foreign Issuer (6-k) 02/27/2017 06:09:23 AM
#5488   Sure, let us wait for this opportunity Maple tree 03/27/17 12:46:10 PM
#5487   I would sell anyone $2 KTOV for $15. mdimport 03/26/17 08:46:23 PM
#5486   Could Drexcel buy out KTOV for $15 or Maple tree 03/25/17 11:05:52 PM
#5485   Maybe... Drexcel wants kit302 for themselves...Could be a HeresJonny 03/25/17 09:40:33 PM
#5484   Scott, Maple tree 03/25/17 06:38:17 PM
#5483   Were going up up up today Doubletree 03/21/17 09:02:14 AM
#5482   It's more a hedge against a doomsday event, scottsmith 03/20/17 08:56:50 AM
#5481   Obviously too each is their own here. RBNEWS 03/19/17 10:58:01 PM
#5480   No need for apologies. This is stock market and Amatuer17 03/19/17 03:34:41 PM
#5479   After thinking about it, my newest best case scottsmith 03/19/17 03:07:32 PM
#5478   My apologies! Though in my defense, the scottsmith 03/19/17 02:59:48 PM
#5477   Ss - you got me interested me in Amatuer17 03/19/17 02:08:49 PM
#5476   Agree. I do think their original statement was RBNEWS 03/19/17 01:27:17 PM
#5475   I would think IR could give an answer tmeier 03/19/17 10:50:14 AM
#5474   I've read a few times now. No RBNEWS 03/18/17 01:59:21 PM
#5473   Question: Is there anything that states that they Buylow2345 03/17/17 08:33:18 PM
#5472   Maybe. Unclear. During the course of scottsmith 03/17/17 08:18:52 PM
#5471   What's your take on filing. Just confirming RBNEWS 03/17/17 07:09:10 PM
#5470   Lot of in's, lot of out's, lot of scottsmith 03/16/17 08:11:49 PM
#5469   I think we've all lost track a little RBNEWS 03/16/17 06:12:30 PM
#5468   Ok thanks scottsmith 03/16/17 05:17:04 PM
#5467   The article you posted the link to, address Rymankoly 03/16/17 05:13:11 PM
#5466   What are you basing your opinion on? scottsmith 03/16/17 04:50:58 PM
#5465   It will have the same effect as other NSAID's Rymankoly 03/16/17 04:38:51 PM
#5464   KIT-302 is badly needed. scottsmith 03/16/17 01:26:27 PM
#5463   Thanks for heads up. I just seen RBNEWS 03/15/17 09:50:55 PM
#5462   Check out the last 6k. Looking like scottsmith 03/15/17 09:40:33 PM
#5461   Why is that? I thought Q1. RBNEWS 03/15/17 09:39:31 PM
#5460   Think you misread the window. scottsmith 03/15/17 09:29:19 PM
#5459   If ever KTOV needed to serve up a RBNEWS 03/15/17 08:52:40 PM
#5458   These ambulance chasers lawsuits typically amount to nothing.Just tmeier 03/15/17 06:30:38 PM
#5457   Should we be worried about the lawsuit in LittleBytor 03/15/17 03:48:33 PM
#5456   Menta Capital LLC raised its stake in shares midastouch017 03/12/17 10:06:45 AM
#5455   Today March 12 TASE closed midastouch017 03/12/17 09:56:11 AM
#5454   There are large trading groups all over the RBNEWS 03/10/17 01:35:00 PM
#5453   Was it not too much too fast to benzene33333 03/10/17 01:06:23 PM
#5452   No doubt on ST and on Nasdaq; but scottsmith 03/10/17 12:32:51 PM
#5451   That is actually the weakest part of my RBNEWS 03/10/17 12:31:11 PM
#5450   Possibly -- your contention is that the pump scottsmith 03/10/17 12:28:00 PM
#5449   I've watched l2 longer than I care to RBNEWS 03/10/17 12:21:43 PM
#5448   Question...On Feb 27th almost 2.4 million common NASDAQ benzene33333 03/10/17 08:56:45 AM
#5447   Yea I miss that price that's for sure!! tmeier 03/09/17 10:59:48 AM
#5446   You mean $3.00 Dollar Bill 03/09/17 06:56:25 AM
#5445   They ran to 2.50 twice last year!!!One time tmeier 03/09/17 12:15:41 AM
#5444   Good, don't know how to play warranty Maple tree 03/08/17 05:19:45 PM
#5443   I added 5k warrants at end of day. scottsmith 03/08/17 04:09:16 PM
#5442   Can anyone give me the scoop on the riverterracekrew 03/08/17 03:05:24 PM
#5441   yap."by the end of March 2017 and to ash111 03/08/17 02:18:14 PM
#5440   In today's 6k -- expected to be submitted scottsmith 03/08/17 02:16:08 PM
#5439   Kitov Successfully Completes All KIT-302 Testing Required for ash111 03/08/17 02:15:03 PM